Inflammation, genes and zinc in Alzheimer's disease

Brain Research Reviews
Sonya VastoCalogero Caruso

Abstract

Alzheimer's disease (AD) is a heterogeneous and progressive neurodegenerative disease which in Western society mainly accounts for clinical dementia. AD has been linked to inflammation and metal biological pathway. Neuro-pathological hallmarks are senile plaques, resulting from the accumulation of several proteins and an inflammatory reaction around deposits of amyloid, a fibrillar protein, Abeta, product of cleavage of a much larger protein, the beta-amyloid precursor protein (APP) and neurofibrillary tangles. Amyloid deposition, due to the accumulation of Abeta peptide, is the main pathogenetic mechanism. Inflammation clearly occurs in pathologically vulnerable regions of AD and several inflammatory factors influencing AD development, i.e. environmental factors (pro-inflammatory phenotype) and/or genetic factors (pro-inflammatory genotype) have been described. At the biochemical level metals such as zinc are known to accelerate the aggregation of the amyloid peptide and play a role in the control of inflammatory responses. In particular, zinc availability may regulate mRNA cytokine expression, so influencing inflammatory network phenotypic expression.

References

May 1, 1991·Archives of Internal Medicine·M K AronsonW Frishman
Nov 15, 1988·Biochemistry·J H Kägi, A Schäffer
May 1, 1994·Biological Signals·C J Frederickson, D W Moncrieff
Jan 1, 1996·Annual Review of Neuroscience·W J Strittmatter, A D Roses
May 24, 1997·Lancet·K MaurerH Gerbaldo
Oct 23, 1997·The Journal of Biological Chemistry·X HuangA I Bush
Mar 4, 2000·Clinical and Experimental Pharmacology & Physiology·G HallidayJ Kril
Apr 20, 2000·Neuroscience Letters·J M KwonA M Goate
May 10, 2000·The Journal of Nutrition·L Rink, H Kirchner
May 10, 2000·The Journal of Nutrition·C J FredericksonR B Thompson
Jun 6, 2000·Trends in Pharmacological Sciences·E MocchegianiR Giacconi
Jun 20, 2000·Neurobiology of Aging·H AkiyamaT Wyss-Coray
Jun 20, 2000·Neurobiology of Aging·K FassbenderK Beyreuther
Oct 26, 2000·Trends in Pharmacological Sciences·J H WeissJ Y Koh
Dec 13, 2000·Brain Research. Brain Research Reviews·A Takeda
Mar 29, 2001·Physiological Reviews·D J Selkoe
Jul 4, 2001·JAMA : the Journal of the American Medical Association·M A AlbertUNKNOWN PRINCE Investigators
Jul 13, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·T QuH Manev
Jul 27, 2001·Brain Research Bulletin·J HidalgoM Vasák
Nov 10, 2001·Annual Review of Genomics and Human Genetics·R W Mahley, S C Rall
Jan 17, 2002·The New England Journal of Medicine·B A in t' VeldB H Stricker
Jun 18, 2002·Ageing Research Reviews·Jonathan D Smith
Jun 18, 2002·Ageing Research Reviews·Arun K RoyBandana Chatterjee
Sep 5, 2002·Annals of Neurology·Reinhold SchmidtLenore J Launer
Oct 23, 2002·Journal of Neuroscience Research·Katsuhiko Yanagisawa
Nov 7, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Pang H ChongCory Franklin
Apr 4, 2003·The New England Journal of Medicine·Robert L Nussbaum, Christopher E Ellis

❮ Previous
Next ❯

Citations

Jun 16, 2010·Biogerontology·Giuseppina CandoreGiuseppina Colonna-Romano
May 22, 2009·Journal of Clinical Immunology·Carmela Rita BalistreriCalogero Caruso
Aug 15, 2012·Journal of Biomolecular Structure & Dynamics·Su-Fang WangGuo-Ying Qian
Mar 30, 2010·Rejuvenation Research·Giuseppina CandoreCalogero Caruso
Apr 27, 2012·Rejuvenation Research·Giulia AccardiGiuseppina Candore
Nov 10, 2009·Immunity & Ageing : I & a·Francesco IemoloCalogero Caruso
Jun 1, 2012·BMC Systems Biology·Satoshi MizunoHiroshi Tanaka
Jan 15, 2011·International Journal of Alzheimer's Disease·Atsushi Takeda
Feb 7, 2014·Immunity & Ageing : I & a·Anna Maria BerghellaPatrizia Pellegrini
Jul 31, 2010·Mediators of Inflammation·Carmela Rita BalistreriGiuseppina Candore
Feb 15, 2011·Expert Opinion on Therapeutic Targets·Kanwaljit ChopraAnurag Kuhad
Apr 16, 2013·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Arnaud DessombzDominique Bazin
Feb 12, 2013·Neurochemistry International·Ann TiimanVello Tõugu
Nov 17, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Barbara C van MunsterSophia E J A de Rooij
Jul 17, 2009·Neurobiology of Aging·Mara D'OnofrioAntonino Cattaneo
May 12, 2009·Frontiers in Neuroendocrinology·Christian J PikeAnna M Barron
Oct 22, 2008·Ageing Research Reviews·Danilo Di BonaCalogero Caruso
Jun 23, 2010·Journal of Neuroscience Research·Atsushi Takeda, Haruna Tamano
Dec 2, 2011·IUBMB Life·Cecília R A SantosIsabel Gonçalves
Aug 10, 2013·IEEE/ACM Transactions on Computational Biology and Bioinformatics·Chien-Ta Tu, Bor-Sen Chen
Oct 16, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Hee-Ju KangJin-Sang Yoon
May 23, 2014·Frontiers in Neurology·Yue-Qin ZengXin-Fu Zhou
Jul 11, 2014·Frontiers in Aging Neuroscience·Sara M HancockPaul A Adlard
Aug 2, 2008·Mechanisms of Ageing and Development·Sonya VastoCalogero Caruso
Mar 6, 2013·Journal of Agricultural and Food Chemistry·Li-Chuan HsuTzu-Ming Pan
Aug 15, 2008·Immunity & Ageing : I & a·Marco RacchiGiovanni Scapagnini
Nov 14, 2019·Current Pharmaceutical Design·Caterina M GambinoMarcello Ciaccio

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Brain Aging

Here is the latest research on intrinsic and extrinsic factors, as well as pathways and mechanisms that underlie aging in the central nervous system.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations with this feed.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Alzheimer's Disease: Transcription

Impaired transcription is associated with the pathogenesis and progression of conditions such as Alzheimer's disease (AD). Here are the latest discoveries pertaining to transcription and AD.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Astrocytes & Amyloid

Astrocytes are thought to play a role in amyloid production and have been implicated in neurodegenerative diseases such as Alzheimer’s disease. Here is the latest research on the relationship between astrocytes and amyloid.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

Aging Epidemiology

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Epidemiology of Aging

This feed focuses on epidemiology of aging and aging-related conditions, including Alzheimer’s disease, dementia, and age-associated cognitive impairment. Here is the latest research.